Much has happened in the field of tremors in the past 10+ years and a newly published book, “Tremors” brings it all together. It shares recent developments in understanding tremor pathology and genetics, as well as the clinical findings in treatment models. Listen to this conversation with one of the co-editors Dr. Claudia Testa, with […]
SAN MATEO, Calif.–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has set a payment determination and benefit category for the existing unique Healthcare Common Procedure Coding System (HCPCS) code K1018 for Cala TAPS therapy, initially put […]
Have You Registered for the ET Virtual Conference? Clinical Trials Need Participants, Apply for a College Scholarship from the IETF
Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced patients’ tremor power by 71%. The Burlingame, California-based company was founded in 2014 as a Stanford University spinout. It makes a wrist-based wearable that uses electrical stimulation to temporarily relieve tremor symptoms.